Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Supplement Article
J Acquir Immune Defic Syndr Volume 75, Supplement 2, June 1, 2017 www.jaids.com
Во всем мире распространенность туберкулеза гораздо выше
в городских районах, чем в сельских. Около 54 % мирового населения
проживает в городах, а развивающиеся ст...аны показывают наиболее
высокие темпы урбанизации. В развитых странах урбанизация привела
к всеобщему улучшению здравоохранения, однако данная тенденция
не нашла отражения в менее развитых регионах мира. В таких странах
ключевые социальные и экономические детерминанты туберкулеза
сходятся на самых бедных группах населения. краткое руководство
Accessed on 2017
more
Rapport sur les populations clès
Accessed November 2017
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Original Research
African Journal of Primary Health Care & Family Medicine
ISSN: (Online) 2071-2936, (Print) 2071-2928
Open Access
Lessons from the STEP-TB Project.
Accessed November 2017.
Information note
Accessed November 2017.
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
PQDx 0159-055-00
WHO PQ Public Report
February/2017, version 5.0
3rd Edition – July 2017
www.msfaccess.org
Guidelines
June 2017
HIV strategic information for impact
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more